Related references
Note: Only part of the references are listed.Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens
Meredith M. Curtis et al.
IMMUNOLOGY (2009)
Protection against Pneumococcal Colonization and Fatal Pneumonia by a Trivalent Conjugate of a Fusion Protein with the Cell Wall Polysaccharide
Ying-Jie Lu et al.
INFECTION AND IMMUNITY (2009)
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice
Zhe Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Nucleic acid delivery with chitosan and its derivatives
Wing-Fu Lai et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines
Gail L. Rodgers et al.
VACCINE (2009)
Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production
Daniela M. Ferreira et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease
Aras Kadioglu et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus
Xiao Wang et al.
VACCINE (2008)
Intranasal immunization with chitosan/pCETP nanoparticles inhibits atherosclerosis in a rabbit model of atherosclerosis
Xiying Yuan et al.
VACCINE (2008)
Streptococcus pneumoniae diseases in Chinese children:: Past, present and future
Kai-hu Yao et al.
VACCINE (2008)
Interleukin-17A mediates acquired immunity to pneumococcal colonization
Ying-Jie Lu et al.
PLOS PATHOGENS (2008)
Antibody-independent, CD4+ T-Cell-Dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins
Alan Basset et al.
INFECTION AND IMMUNITY (2007)
Induction of secretory immunity and memory at mucosal surfaces
Per Brandtzaeg
VACCINE (2007)
The introduction of new vaccines into developing countries - IV: Global access strategies
Richard T. Mahoney et al.
VACCINE (2007)
Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: Otitis media and acute pneumonia
Allan W. Cripps et al.
VACCINE (2007)
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006)
Froukje Oosterhuis-Kafeja et al.
VACCINE (2007)
Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen a fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice
F. C. Pimenta et al.
INFECTION AND IMMUNITY (2006)
Enhanced protective immunity against pneumococcal infection with PspA DNA and protein
Quincy C. Moore et al.
VACCINE (2006)
Streptococcus pneumoniae protein vaccine candidates:: Properties, activities and animal studies
Stanley S. Tai
CRITICAL REVIEWS IN MICROBIOLOGY (2006)
Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A
Maria Leonor Sarno Oliveira et al.
MICROBES AND INFECTION (2006)
Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide
R Malley et al.
INFECTION AND IMMUNITY (2006)
DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein
DM Ferreira et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Mucosal vaccines: the promise and the challenge
MR Neutra et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization
R Malley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mucosal immunity induced by pneumococcal glycoconjugate
CJ Lee et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2005)
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
HO Alpar et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Advances in pneumococcal vaccines - Advantages for infants and children
J Bernatoniene et al.
DRUGS (2005)
Streptococcus pneumoniae colonisation:: the key to pneumococcal disease
D Bogaert et al.
LANCET INFECTIOUS DISEASES (2004)
Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection
W Xu et al.
VACCINE (2004)
Expression and characterization of cholera toxin B -: pneumococcal surface adhesin A fusion protein in Escherichia coli:: ability of CTB-PsaA to induce humoral immune response in mice
APM Areas et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Essential role for the p40 subunit of interleukin-12 in neutrophil-mediated early host defense against pulmonary infection with Streptococcus pneumoniae:: involvement of interferon-γ
N Yamamoto et al.
MICROBES AND INFECTION (2004)
Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria
Q Zhang et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nasal drug delivery - possibilities, problems and solutions
L Illum
JOURNAL OF CONTROLLED RELEASE (2003)
Mucosal immunization with DNA vaccines
P Hobson et al.
METHODS (2003)
Enhanced immunogenicity of pneumococcal surface adhesin A by genetic fusion to cytokines and evaluation of protective immunity in mice
DO Gor et al.
INFECTION AND IMMUNITY (2002)
Pneumococcal infections in humans are associated with increased apoptosis and trafficking of type 1 cytokine-producing T cells
K Kemp et al.
INFECTION AND IMMUNITY (2002)
In vivo characterization of the psa genes from Streptococcus pneumoniae in multiple models of infection
A Marra et al.
MICROBIOLOGY-SGM (2002)
Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesin A
SE Johnson et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae
EN Miyaji et al.
VACCINE (2001)
Chitosan for mucosal vaccination
IM van der Lubben et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Active bacterial core surveillance of the emerging infections program network
A Schuchat et al.
EMERGING INFECTIOUS DISEASES (2001)
Cutting edge: The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues
FW van Ginkel et al.
JOURNAL OF IMMUNOLOGY (2000)
The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection
DE Briles et al.
VACCINE (2000)
Share Paper
